Clinical Trials Directory

Trials / Completed

CompletedNCT00784784

Zanamivir Versus Trivalent Split Virus Influenza Vaccine

A Pilot Study for a Randomized Controlled Trial to Compare Trivalent Split Virus Influenza Vaccine to Seasonal Antiviral Prophylaxis in Healthcare and Other Healthy Adults: Assessment of Zanamivir Versus Vaccine (Stop-Flu-2)

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Mount Sinai Hospital, Canada · Academic / Other
Sex
All
Age
18 Years – 69 Years
Healthy volunteers
Accepted

Summary

This unblinded pilot study is intended to assess the feasibility of a larger double-blind, randomized control trial. For the larger trial the investigators are interested in understanding the relative benefits of vaccine and antiviral prophylaxis, the risk factors for influenza infection in healthy adults, and in assessing the safety and tolerability of seasonal antiviral prophylaxis in healthcare workers. The pilot study will be assessing the rate of infection with influenza and the rate of adherence to long-term zanamivir in 60 healthy volunteers.

Detailed description

Several studies have demonstrated that zanamivir and oseltamivir are effective in preventing influenza infection and illness when used either as prophylaxis after exposure to a household contact with influenza or when taken for several weeks at the height of influenza activity in the general community. However, the longest duration of prophylaxis with neuraminidase inhibitors in two clinical trials, to date, has been six weeks. Antiviral medication will likely have an important role in the response to the next influenza pandemic. Additionally, there may be indications for use during seasons when the major infecting strain of influenza in not one whose antigen is well covered by the vaccine.

Conditions

Interventions

TypeNameDescription
BIOLOGICALFluviralOne dose
DRUGZanamivir10 mg, OD, for duration of influenza season (10-23 weeks)

Timeline

Start date
2008-11-01
Primary completion
2009-05-01
Completion
2009-06-01
First posted
2008-11-04
Last updated
2014-11-21
Results posted
2011-09-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00784784. Inclusion in this directory is not an endorsement.